Kalmar Corporation
Kalmar Corporation signed EUR 200 million revolving credit facility
Kalmar Corporation signed EUR 200 million revolving credit facility
KALMAR CORPORATION, PRESS RELEASE, 13 DECEMBER 2024 AT 17:00 PM (EET)
Kalmar Corporation signed EUR 200 million revolving credit facility
Kalmar Corporation has entered into a EUR 200 million revolving credit facility with a syndicate of its six relationship banks on 13 December 2024. The facility has a tenor of five years with two one-year extension options subject to the lenders’ approval. The purpose of this facility is to refinance the existing EUR 150 million euros bilateral revolving credit facilities maturing in 2025 and 2027 and general corporate purposes of the group.
With this facility, Kalmar strengthens its long-term liquidity position.
The facility was coordinated by SEB and the Mandated Lead Arrangers and Bookrunners are BNP Paribas, Danske Bank, Nordea Bank, OP Corporate Bank, SEB (Facility Agent) and Standard Chartered Bank.
For further information, please contact:
Sakari Ahdekivi, CFO, tel. +358 50 400 3557
Ilari Pajunen, Vice President, Treasury, puh. +358 20 777 4000
About Kalmar
Kalmar (Nasdaq Helsinki: KALMAR) is moving goods in critical supply chains around the world, with the vision to be the forerunner in sustainable material handling equipment and services. The company offers a wide range of industry shaping heavy material handling equipment and services to ports and terminals, distribution centres, manufacturing and heavy logistics. Headquartered in Helsinki, Finland, Kalmar operates globally in over 120 countries and employs approximately 5,200 people. In 2023, the company's sales totalled approximately EUR 2.0 billion. www.kalmarglobal.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S17.9.2025 23:05:02 CEST | Press release
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
Biogen Inc.17.9.2025 22:30:05 CEST | Press release
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
Atico Mining Corporation17.9.2025 22:30:00 CEST | Press release
Atico Signs the Investment Protection Agreement with Government of Ecuador for its La Plata Project
Frontline plc.17.9.2025 22:06:51 CEST | Press release
FRO – Filing of Half Yearly Report
VCI Global Limited17.9.2025 21:00:00 CEST | Press release
VCI Global Initiates Rescission and Cancellation of Shares from QuantGold Transaction, Tightening Capital Structure Following Reverse Split
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom